garamycin 40 mg/ml injektionsvätska, lösning
schering plough europe - gentamicinsulfat - injektionsvätska, lösning - 40 mg/ml - gentamicinsulfat aktiv substans; propylparahydroxibensoat hjälpämne; natriummetabisulfit hjälpämne; metylparahydroxibensoat hjälpämne - gentamicin
garamycin 80 mg/ml injektionsvätska, lösning
schering plough europe - gentamicinsulfat - injektionsvätska, lösning - 80 mg/ml - gentamicinsulfat aktiv substans; propylparahydroxibensoat hjälpämne; metylparahydroxibensoat hjälpämne; natriummetabisulfit hjälpämne - gentamicin
celeston valerat med gentamicin vet. kräm
schering-plough a/s - betametasonvalerat; gentamicinsulfat - kräm - betametasonvalerat 1,22 mg aktiv substans; gentamicinsulfat aktiv substans; klorkresol hjälpämne; cetostearylalkohol hjälpämne - betametason och antibiotika - samtliga
septopal 4,5 mg kedja för implantation
merck kgaa - gentamicinsulfat; zirkoniumdioxid - kedja för implantation - 4,5 mg - zirkoniumdioxid 20 mg aktiv substans; gentamicinsulfat 7,5 mg aktiv substans - gentamicin
garamycin 0,1 % kräm
schering plough europe - gentamicinsulfat - kräm - 0,1 % - cetostearylalkohol hjälpämne; klorkresol hjälpämne; gentamicinsulfat aktiv substans - gentamicin
otomax vet. örondroppar, suspension
intervet international b.v. - betametasonvalerat; gentamicinsulfat; klotrimazol - Örondroppar, suspension - gentamicinsulfat 2640 ie aktiv substans; betametasonvalerat 1,07 mg aktiv substans; klotrimazol 8,8 mg aktiv substans - betametason och antiinfektiva medel - hund
purevax rc
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - immunologicals för kattdjur, - katter - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.
purevax rcp
boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologicals för kattdjur, - katter - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.
purevax rcp felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals för kattdjur, - katter - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcpch
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologicals för kattdjur, - katter - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. immunitetens intrång har visats en vecka efter primärvaccinationskurs för rinotrakeit, kalicivirus, chlamydophila felis och panleukopeni-komponenter. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.